Improvement in Cognition by α7 Nicotinic Acetylcholine Receptor Partial Agonist APN1125 in Preclinical Models as a Prologue to Clinical Development

被引：0

作者：

Detke, Michael J. ^{[1
,2
]}

Stevens, Karen E. ^{[3
]}

Koelsch, Gerald ^{[4
]}

Anderson, Paul C. ^{[4
]}

Meltzer, Leonard T. ^{[5
]}

Yoshimura, Ryan F. ^{[6
]}

Bilcer, Geoffrey ^{[7
]}

Ng, John ^{[8
]}

Ng, Raymond ^{[8
]}

Gee, Kelvin W. ^{[6
]}

Kelly, Terence A. ^{[7
]}

机构：

[1] CoMentis, Clin, San Francisco, CA USA

[2] Indiana Univ, San Francisco, CA USA

[3] Univ Colorado, Psychiat, Denver, CO 80202 USA

[4] CoMentis & Alpharmagen, Biol, San Francisco, CA USA

[5] L Meltzer CNS Consulting, Biol, Ann Arbor, MI USA

[6] Alpharmagen & Anvyl, Biol, San Francisco, CA USA

[7] CoMentis & Alpharmagen, Chem, San Francisco, CA USA

[8] CoMentis & Alpharmagen, CMC, San Francisco, CA USA

来源：

关键词：

nicotinic; cognition; schizophrenia;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

738

引用

页数：1